This document discusses occupational cancers and preventive strategies. It defines how carcinogens are identified and classified differently across countries. Approximately 2-8% of cancers are related to occupations, with certain chemicals and industries linked to increased risks of specific cancer types. Biomarkers can help assess exposure to known carcinogens like tobacco smoke and aflatoxin. The International Agency for Research on Cancer (IARC) classifies agents as Group 1 (carcinogenic to humans), Group 2A (probably carcinogenic), Group 2B (possibly carcinogenic) or Group 3 (unclassifiable) based on evidence from human and animal studies. Preventive measures include banning known carcinogens from industry and replacing them with safer substitutes when possible
2-8% of cancers are caused by occupational exposures. Certain occupations are associated with increased risks of specific cancers, such as lung cancer from asbestos, arsenic, chromium and nickel exposure. Prevention through controlling exposures, smoking cessation, and medical monitoring can help reduce cancer risks from the workplace. Epidemiological studies help identify occupational carcinogens and estimate cancer risks but have limitations like long latency periods and confounding factors.
This document outlines a lecture on occupational cancer. It begins with definitions of cancer and occupational cancer. It then discusses the global and national burden of cancer, noting that over 5 million new cancer cases occur worldwide annually and occupational exposures are responsible for 2-10% of cancer cases. The lecture covers carcinogenesis principles, strategies for identifying occupational carcinogens like epidemiological studies and toxicity testing, classes of carcinogens from IARC, and primary prevention methods like eliminating exposures and using protective equipment. It raises challenges around occupational cancer research and prevention.
My presentation at the IOSH National Safety Symposium, 7th and 8th September 2014.
http://www.iosh.co.uk/Key-IOSH-events/National-Safety-Symposium.aspx
The document summarizes a discussion on controlling occupational exposure to carcinogenic chemicals. The discussion focused on the effectiveness of risk minimization measures listed in Article 5 of the EU Directive on carcinogens, including prevention, closed systems, engineering controls and exposure limits. Participants considered questions around the suitability and practicality of the required measures and whether the Directive adequately describes best practices for controlling carcinogen exposures. The discussion aims to inform a project assessing socioeconomic and health impacts of carcinogen exposure limits and identifying opportunities to strengthen the Directive.
Industrial and agricultural activities over the last 50 years have significantly increased the concentration of toxic pollutants in the environment such as PAHs, PCBs, chlorophenols, nitrophenols, and BTEX. Most of these substances are mutagenic and carcinogenic. Environmental pollution accounts for over 55% of all cancers according to the WHO. Carcinogens may be chemical, physical, or biological agents that can cause cancer. They may act as initiators that alter DNA or promoters that encourage uncontrolled cell growth. Cancer rates are expected to increase significantly in the coming decades due to rising environmental pollution.
The document summarizes the work of the IARC Monographs Program in evaluating potential carcinogens. Over 950 agents have been evaluated, with 110 found to be carcinogenic to humans. National health agencies use the Monographs to prevent exposure to known or suspected carcinogens. Recent Monographs have increasingly incorporated mechanistic data to identify carcinogens, even in the absence of cancer studies. Future work includes further analyzing concordance between human and animal tumors, key carcinogenic mechanisms, and identifying priorities for evaluation using advisory groups.
This document discusses the aetiology of neoplasia (tumor development). It identifies several risk factors for cancer development including age, genetics, environment, and lifestyle habits. It describes how various carcinogenic agents like chemicals, radiation, viruses, and hormones can cause DNA damage and genetic mutations over time, leading to cancer initiation and promotion. Specifically, it explains how ionizing radiation, ultraviolet light, viruses, chemicals, and hormones may contribute to cancer development and progression through their effects on DNA and cell proliferation.
This document discusses the etiology of cancer. It classifies etiological factors into extrinsic (chemical, physical, biological) and intrinsic (genetic, hormonal, immune) factors. Extrinsic factors predominate in causing adult cancers while intrinsic factors are more common in pediatric cancers. Major extrinsic factors include chemicals, radiation, infections, and tobacco. Chemicals can directly or indirectly damage DNA. Radiation can directly or indirectly ionize DNA. Certain viruses and bacteria are associated with specific cancer types. The interaction between multiple genetic and environmental factors usually leads to cancer development.
Carcinogens are substances capable of causing cancer. They cause damage after repeated or long-term exposure and cancer may develop only after a long latency period. Various materials and chemicals are known carcinogens, including asbestos, tobacco smoke, ionizing radiation, and hundreds of individual chemical compounds. Carcinogenicity is determined through epidemiological studies of human populations and animal studies. Exposure to carcinogens can be reduced through engineering controls like exhaust ventilation, personal protective equipment, hygiene practices, and administrative controls.
The document discusses several environmental problems related to arsenic contamination of water supplies. It notes that arsenic poisoning has affected over 200 million people worldwide and outlines regions that have arsenic levels above WHO guidelines, including Bangladesh, India, China and others. The health effects of arsenic exposure are explained, including cancers of the skin, lungs, and other organs. The document also discusses other environmental issues like ozone depletion, UV radiation effects, and approaches to bioremediation of pollutants.
The document discusses carcinogens and cancer. It defines carcinogens as substances that are capable of causing cancer. Carcinogens can include chemicals, viruses, radiation, and certain lifestyle factors. The ability of a carcinogen to cause cancer depends on factors like exposure time, type of carcinogen, and individual health. Some specific carcinogens mentioned include benzene, arsenic, cadmium, radon, and asbestos which have been linked to various cancers like leukemia, lung cancer, and mesothelioma. Carcinogens can cause DNA damage and mutations which may lead to malignant cell transformation and cancer. Protective measures and minimizing exposure to known carcinogens can help reduce cancer risk.
This document provides an overview of chemical risk assessment and toxicology as it relates to foods and food ingredients. It discusses key concepts in toxicology like dose-response relationships, factors that influence toxicity, and the absorption, distribution, metabolism and excretion of toxicants in the body. It then explains the risk assessment process and considers acrylamide as a case study, discussing its properties, levels found in various foods, and cancer bioassay results. It also reviews epidemiology studies that found no increased cancer risk from dietary acrylamide exposure.
Carcinogenic agents and their cellular interactionsShoaib Afridi
油
Sir Percival Pott correctly linked scrotal cancer in chimney sweeps to exposure to soot over 200 years ago. There are three main classes of carcinogenic agents that can cause genetic damage and cancer: chemicals, radiant energy, and microbial agents. Chemicals and radiant energy are documented human carcinogens, while oncogenic viruses are involved in cancer in some animal and human tumors.
Neoplasia cancer presentation for medicalMeMyself84
油
This document discusses risk factors for cancer development. It identifies lifestyle factors like environment, reproductive life, diet, smoking and alcohol as risk factors. It also discusses carcinogenic agents like radiation, chemicals and infectious pathogens. Other risk factors mentioned are age, as cancer risk increases with age, and hereditary factors which account for 5-10% of cancers. The document also identifies some pre-neoplastic conditions that increase cancer risk.
Module 7 - Radiation and Chemical Mutagens 2 - Midterm.pptxMarkLouBalinwang
油
This document discusses various sources of radiation and chemical mutagens. It describes how ionizing radiation and chemical mutagens can cause mutations in DNA, potentially leading to cancer. Specific sources of radiation exposure discussed include medical imaging, nuclear weapons testing, nuclear power plants, and UV radiation from the sun. Many known chemical carcinogens and mutagens are also listed, including aflatoxins, benzidine, acrylonitrile, and formaldehyde. The document also explores how epidemiological studies, animal testing, and screening tests are used to identify carcinogens and teratogens, which are chemicals that cause birth defects.
_Role_of_free_radicals_in_cancer M pharmacy PharmacologyAyodhya Paradhe
油
Free radicals are reactive molecules that can damage cells and DNA. High levels of free radicals and oxidative stress can lead to mutations that cause cancer. Many cancer-causing factors like tobacco, UV light, and inflammation increase free radical production. Curcumin and vitamins C and E are antioxidants that can prevent cancer by reducing oxidative stress and blocking enzymes involved in cancer formation and growth. Intravenous vitamin C treatment for cancer works by increasing oxidative stress in cancer cells through hydrogen peroxide production, altering gene expression, and inhibiting tumor invasion and metastasis. Antioxidants and lifestyle changes may help prevent cancer by lowering free radical levels and reducing cancer risk from environmental exposures.
The document discusses approaches to detoxifying heavy metals, focusing on chelation therapy using CaNa2-EDTA suppositories (Detoxamin). It notes 99% of 200 patients tested showed toxic heavy metal levels. Detoxamin is described as a safe, non-invasive way to chelate metals like mercury, lead and cadmium. Clinical trials show Detoxamin effectively increases metal excretion compared to intravenous chelation.
Topic 5 physical and chemical carcinogensisa bella
油
This document summarizes physical and chemical carcinogens (cancer-causing agents). It defines carcinogens as substances capable of causing cancer and notes they typically cause damage after repeated or long-term exposure. Carcinogens are classified as physical (e.g. asbestos, radiation) or chemical (e.g. polycyclic aromatic hydrocarbons, metals). Several specific carcinogens are discussed in detail, including their mechanisms of inducing cancer development over long latency periods through DNA damage and disruption of cell growth processes. The largest sources of exposure to carcinogens are identified as cigarette smoking, certain occupations, and combustion/industrial activities.
Updating the european carcinogens directiveRetired
油
This document discusses occupational cancer risks and the European Carcinogens Directive. It summarizes a study that found increased mortality from cancers like lung cancer and bladder cancer in workers exposed to carcinogens at a coal plant. The directive aims to prevent risks from carcinogen exposure, but its requirements need updating. An estimated 5.3% of cancers in men are attributable to occupational exposure. Exposures have decreased over time but the cancer burden is still high. Updating exposure limits for substances like crystalline silica could significantly reduce future cancer cases and costs.
Presentation on Chemical Hazards in Industry and protection of workers, diagnosis of adverse health effects. Creating their awareness and guidance to Doctors.
This document provides an overview of antineoplastic agents and recently approved drugs used to treat cancer. It defines cancer and describes the main types. The classification of anticancer drugs is discussed, including drugs that act directly on cells like alkylating agents, antimetabolites, natural products, antibiotics, and miscellaneous drugs. Drugs that act on hormones are also summarized. Recently approved drugs by the FDA from 2013-2016 for cancers like lung cancer, breast cancer, and leukemia are listed with their uses. References are included from medical pharmacology textbooks and FDA websites.
The document outlines James Coughlin's presentation on various food additives, contaminants, and herbal supplements. It discusses topics like caffeine and energy drinks, heat-processed carcinogens like acrylamide and furan, lead and arsenic issues, nitrite and nitrate under Proposition 65, and key herbal supplements being evaluated by organizations like the National Toxicology Program and International Agency for Research on Cancer. The presentation aims to provide an overview of the current state of research and regulatory considerations for several substances of potential concern in the food supply.
This document discusses the aetiology of neoplasia (tumor development). It identifies several risk factors for cancer development including age, genetics, environment, and lifestyle habits. It describes how various carcinogenic agents like chemicals, radiation, viruses, and hormones can cause DNA damage and genetic mutations over time, leading to cancer initiation and promotion. Specifically, it explains how ionizing radiation, ultraviolet light, viruses, chemicals, and hormones may contribute to cancer development and progression through their effects on DNA and cell proliferation.
This document discusses the etiology of cancer. It classifies etiological factors into extrinsic (chemical, physical, biological) and intrinsic (genetic, hormonal, immune) factors. Extrinsic factors predominate in causing adult cancers while intrinsic factors are more common in pediatric cancers. Major extrinsic factors include chemicals, radiation, infections, and tobacco. Chemicals can directly or indirectly damage DNA. Radiation can directly or indirectly ionize DNA. Certain viruses and bacteria are associated with specific cancer types. The interaction between multiple genetic and environmental factors usually leads to cancer development.
Carcinogens are substances capable of causing cancer. They cause damage after repeated or long-term exposure and cancer may develop only after a long latency period. Various materials and chemicals are known carcinogens, including asbestos, tobacco smoke, ionizing radiation, and hundreds of individual chemical compounds. Carcinogenicity is determined through epidemiological studies of human populations and animal studies. Exposure to carcinogens can be reduced through engineering controls like exhaust ventilation, personal protective equipment, hygiene practices, and administrative controls.
The document discusses several environmental problems related to arsenic contamination of water supplies. It notes that arsenic poisoning has affected over 200 million people worldwide and outlines regions that have arsenic levels above WHO guidelines, including Bangladesh, India, China and others. The health effects of arsenic exposure are explained, including cancers of the skin, lungs, and other organs. The document also discusses other environmental issues like ozone depletion, UV radiation effects, and approaches to bioremediation of pollutants.
The document discusses carcinogens and cancer. It defines carcinogens as substances that are capable of causing cancer. Carcinogens can include chemicals, viruses, radiation, and certain lifestyle factors. The ability of a carcinogen to cause cancer depends on factors like exposure time, type of carcinogen, and individual health. Some specific carcinogens mentioned include benzene, arsenic, cadmium, radon, and asbestos which have been linked to various cancers like leukemia, lung cancer, and mesothelioma. Carcinogens can cause DNA damage and mutations which may lead to malignant cell transformation and cancer. Protective measures and minimizing exposure to known carcinogens can help reduce cancer risk.
This document provides an overview of chemical risk assessment and toxicology as it relates to foods and food ingredients. It discusses key concepts in toxicology like dose-response relationships, factors that influence toxicity, and the absorption, distribution, metabolism and excretion of toxicants in the body. It then explains the risk assessment process and considers acrylamide as a case study, discussing its properties, levels found in various foods, and cancer bioassay results. It also reviews epidemiology studies that found no increased cancer risk from dietary acrylamide exposure.
Carcinogenic agents and their cellular interactionsShoaib Afridi
油
Sir Percival Pott correctly linked scrotal cancer in chimney sweeps to exposure to soot over 200 years ago. There are three main classes of carcinogenic agents that can cause genetic damage and cancer: chemicals, radiant energy, and microbial agents. Chemicals and radiant energy are documented human carcinogens, while oncogenic viruses are involved in cancer in some animal and human tumors.
Neoplasia cancer presentation for medicalMeMyself84
油
This document discusses risk factors for cancer development. It identifies lifestyle factors like environment, reproductive life, diet, smoking and alcohol as risk factors. It also discusses carcinogenic agents like radiation, chemicals and infectious pathogens. Other risk factors mentioned are age, as cancer risk increases with age, and hereditary factors which account for 5-10% of cancers. The document also identifies some pre-neoplastic conditions that increase cancer risk.
Module 7 - Radiation and Chemical Mutagens 2 - Midterm.pptxMarkLouBalinwang
油
This document discusses various sources of radiation and chemical mutagens. It describes how ionizing radiation and chemical mutagens can cause mutations in DNA, potentially leading to cancer. Specific sources of radiation exposure discussed include medical imaging, nuclear weapons testing, nuclear power plants, and UV radiation from the sun. Many known chemical carcinogens and mutagens are also listed, including aflatoxins, benzidine, acrylonitrile, and formaldehyde. The document also explores how epidemiological studies, animal testing, and screening tests are used to identify carcinogens and teratogens, which are chemicals that cause birth defects.
_Role_of_free_radicals_in_cancer M pharmacy PharmacologyAyodhya Paradhe
油
Free radicals are reactive molecules that can damage cells and DNA. High levels of free radicals and oxidative stress can lead to mutations that cause cancer. Many cancer-causing factors like tobacco, UV light, and inflammation increase free radical production. Curcumin and vitamins C and E are antioxidants that can prevent cancer by reducing oxidative stress and blocking enzymes involved in cancer formation and growth. Intravenous vitamin C treatment for cancer works by increasing oxidative stress in cancer cells through hydrogen peroxide production, altering gene expression, and inhibiting tumor invasion and metastasis. Antioxidants and lifestyle changes may help prevent cancer by lowering free radical levels and reducing cancer risk from environmental exposures.
The document discusses approaches to detoxifying heavy metals, focusing on chelation therapy using CaNa2-EDTA suppositories (Detoxamin). It notes 99% of 200 patients tested showed toxic heavy metal levels. Detoxamin is described as a safe, non-invasive way to chelate metals like mercury, lead and cadmium. Clinical trials show Detoxamin effectively increases metal excretion compared to intravenous chelation.
Topic 5 physical and chemical carcinogensisa bella
油
This document summarizes physical and chemical carcinogens (cancer-causing agents). It defines carcinogens as substances capable of causing cancer and notes they typically cause damage after repeated or long-term exposure. Carcinogens are classified as physical (e.g. asbestos, radiation) or chemical (e.g. polycyclic aromatic hydrocarbons, metals). Several specific carcinogens are discussed in detail, including their mechanisms of inducing cancer development over long latency periods through DNA damage and disruption of cell growth processes. The largest sources of exposure to carcinogens are identified as cigarette smoking, certain occupations, and combustion/industrial activities.
Updating the european carcinogens directiveRetired
油
This document discusses occupational cancer risks and the European Carcinogens Directive. It summarizes a study that found increased mortality from cancers like lung cancer and bladder cancer in workers exposed to carcinogens at a coal plant. The directive aims to prevent risks from carcinogen exposure, but its requirements need updating. An estimated 5.3% of cancers in men are attributable to occupational exposure. Exposures have decreased over time but the cancer burden is still high. Updating exposure limits for substances like crystalline silica could significantly reduce future cancer cases and costs.
Presentation on Chemical Hazards in Industry and protection of workers, diagnosis of adverse health effects. Creating their awareness and guidance to Doctors.
This document provides an overview of antineoplastic agents and recently approved drugs used to treat cancer. It defines cancer and describes the main types. The classification of anticancer drugs is discussed, including drugs that act directly on cells like alkylating agents, antimetabolites, natural products, antibiotics, and miscellaneous drugs. Drugs that act on hormones are also summarized. Recently approved drugs by the FDA from 2013-2016 for cancers like lung cancer, breast cancer, and leukemia are listed with their uses. References are included from medical pharmacology textbooks and FDA websites.
The document outlines James Coughlin's presentation on various food additives, contaminants, and herbal supplements. It discusses topics like caffeine and energy drinks, heat-processed carcinogens like acrylamide and furan, lead and arsenic issues, nitrite and nitrate under Proposition 65, and key herbal supplements being evaluated by organizations like the National Toxicology Program and International Agency for Research on Cancer. The presentation aims to provide an overview of the current state of research and regulatory considerations for several substances of potential concern in the food supply.
1. Occupational Cancers
and
Preventive Strategies
Dr. Manish Singhal MD, DM (AIIMS), ECMO (Gold Medal)
European Certified Medical Oncologist
Ex. Committee Member - Ind. Soc of Med & Ped Oncology (ISMPO)
Jt. Sec NCR Oncology Forum
Senior Consultant Medical Oncology
Dharamshila Hospital and Research Center
New Delhi
2. DEFINING OF CARCINOGENS
The control of occupational carcinogenic
substance is exercised by scientific researches on
human beings and experimental modeling
systems.
It differs from some countries to other's
because of differences in legislative
implementations. For example, a certain
chemical was defined as carcinogen in Finland,
after a while Denmark marked it as carcinogen.
In this period ACGIH(American Conference of
Industrial Hygienists) accepted it as suspicious
carcinogen.
3. HOW MUCH ARE CANCERS RELATED TO
OCCUPATIONS?
2-8% (1981 Doll &Peto)
Every year 25,000-100,000 new case in USA
Data is not available in India
4. OCCUPATIONAL CANCER
First occupational cancer case:
Scrotum cancer(1775)- Percival Pott
Exposure of chimney sweep to soot
Some polycyclic hydrocarbons were
defined-1930
5. Exposure
Exogenous
Endogenous
Genetic
Susceptibility
Occupational
cancer
The extent to which chemical exposures contribute to cancer incidence
was not fully appreciated until population-based studies documented
differing organ-specific cancer rates of up to 300-fold among geographically
distinct populations.
Carcinogenesis is a multistage process
Behind each stage are numerous genetic
events
Wide inter-individual variation in response to carcinogen exposure
The human response is not homogeneous.
6. Virtually every major form of human cancer can be reproduced in experimental
animals by exposure to specific chemical carcinogens
Animal models have revealed the constancy of carcinogen-host
interaction among mammalian species
Coal tar Squamous cell carcinomas
Vinyl chloride Hepatic angiosarcomas
Aflatoxin Hepatocarcinoma
Aromatic amines Bladder cancer.
Oncogene
Tumor Suppressor
gene
Failure of DNA repair
7. The National Toxicology Program lists more than 200 chemical, physical
and infectious agents as known or probable environmental carcinogens.
Genotoxic Non-Genotoxic
Chemical carcinogen
Cytochrome P-450
The interaction with DNA is not random:
each class of agents reacts selectively
with purine and pyrimidine targets
DNA Adducts
By transfer of alkyl
or aryl-alkyl gp
-N-nitroso
compounds
-Aliphatic
epoxides
- Aflatoxins
- Mustards
- Polycyclic
Aromatic HC
- Aryl aromati
amines
-Aminoazo
dyes
-Heterocyclic
aromatic
amines
Missense or nonsense mutations
macrogenetic damage
- chromosome breaks
- large deletions
Signature Mutation p53
Mechanism?
- Toxic cell death
- Regenerative hyperplasia
- Oxyradical damage
- Depurination
- Deamination
- Hormonal effects
Pesticides and herbicide
Need long continued exposure
Oncogene
Tumor Suppressor
gene
8. Benzene as a Model for Gene-Environment Interaction
Benzene exposure is widespread among a number of occupational groups : oil and gas industry,
automotive repair, shoe manufacturing, also from cigarette smoke, gasoline, and automobile exhaust.
Benzene is linked to hematologic toxicity including aplastic anemia, and acute myeloid leukemia.
benzene oxide and hydroquinone
Reactive benzoquinones
myeloperoxidase
covalent binding to DNA
alterations in gene expression
chromosomal aberrations
CYP4502E1
Benzene
Liver
Bone Marrow
Leukemia
Functional
Polymorphism
decreasing activity
MPO
NAD(P):quinone oxidoreductase
Functional
Polymorphism
decreasing activity
Quinone Oreductase
9. Target
organ
Agent Industry Tumor type
Lung Tobacco smoke, arsenic, asbestos,
crystalline silica, benzo(a)pyrene,
beryllium, ether, 1,3-butadiene, chromium
compounds, coal tar and pitch, nickel
compounds, soots, mustard gas
Aluminum production,
coal gasification, coke
production, hematite-
mining, painters
Squamous, large cell, and
small cell cancer and
adenocarcinoma
Pluera Asbestos, erionite - Mesothelioma
Oral
cavity &
esophagus
Tobacco smoke, alcoholic beverages, nickel
compounds
Boot and shoe production,
furniture manufacturer,
isopropyl alcohol
production
Squamous cell ca
Gastric Smoked, salted and pickled foods Rubber Adenocarcinoma
Colon Heterocyclic amines, asbestos Pattern maker Adenocarcinoma
Liver Aflatoxin, vinyl chloride, tobacco smoke,
alcoholic beverages, thorium dioxide
- Hepatocellular carcinoma,
hemangiosarcoma
Kidney Tobacco smoke, phenacetin RCC
Bladder Tobacco smoke, 4-aminobiphenyl,
benzidine, 2-napthylamine, phenacetin
Magenta Manufacturer Transitional cell ca
Prostate Cadmium - Adenocarcinoma
Skin Arsenic, benzo(a)pyrene, coal tar and pitch,
mineral oils, soots, cyclosporin A, PUVA
Coal gasification, coke
production
Sqamous cell ca
Basal cell ca
Bone
Marrow
Benzene, tobacco smoke, ethylene oxide,
antineoplastic agents, cyclosporin A
Rubber workers
Oil & petroleum
Leukemia and lymphoma
10. Physical factors
UVC 240 to 290 nm mercury lamps -used for
sterilization
DNA interactions dimers
between adjacent
pyrimidines
UVB 290 to 320 nm Skin cancer DNA interactions dimers
between adjacent
pyrimidines
UVA 320 to 400 nm Carcinogenic though
weakly absorbed by
DNA
production of reactive
oxygen species through its
interactions with target
chromophores
11. Ionizing radiation
ATOMIC BOMB
Japanese survivors
OCCUPATIONAL EXPOSURES
Radiologists
Underground miners
Radium dial painters
Nuclear workers
Radiation technologists
MEDICAL EXPOSURES
Ankylosing spondylitis patients
Tinea capitis
Thymic enlargement
Benign breast disease
Benign gynecologic disease
Fluoroscopy during treatment for
tuberculosis
Cervical cancer
Hodgkin's lymphoma
Breast cancer
Childhood cancer
Mechanism Double stranded DNA breaks
Leading to chromosomal instability, mutations
and rearrangements
At Low dose levels 200mGy additive effect !
Equivalent whether the dose was received all at once
or accumulated over a long period of time
At Higher dose level 2-3 Gy
dose rate reduction factor (DREF).
Carcinogenic risks after fractionated exposures
are lower than after single acute exposures
12. Approximate Mean Doses for Selected Exposures to Ionizing
Radiation
Exposure Mean Individual Dose (mSv)
Round-trip flight, New York to London 0.1
Single screening mammogram (breast
dose)
3
Background dose due to natural
radiation exposure
3/y
Pediatric computed tomography scan
(stomach dose from abdominal scan)
25
Radiation worker exposure limit 20/y
Exposure on international space station 170/y
14. Biomarkers of Cancer Risk
External exposure measurements
Internal exposure measurements
Biomarkers estimating the biologically effective dose
Biomarkers of harm
- Biomarkers are available to assess N-nitrosamine exposure from
tobacco smoke (e.g., urinary tobacco specific nitrosamine levels)
- Urinary aflatoxin adduct levels vary among regions of the world,
- There are several methods for detecting PAH DNA adducts as well
as measuring PAH metabolites in the urine.
No single biomarker has been considered to be sufficiently
validated for use as a cancer risk marker in an individual
15. IARC
The International Agency for
Research on Cancer (IARC) is part
of the World Health Organization.
IARC's mission is to coordinate and conduct research on the
causes of human cancer, the mechanisms of carcinogenesis,
and to develop scientific strategies for cancer prevention and
control. The Agency is involved in both epidemiological and
laboratory research and disseminates scientific information
through publications, meetings, courses, and fellowships.
16. The International Agency for
Research on Cancer (IARC )CLASSIFICATION
Group 1: Carcinogenic to humans
Group 2A: Probably carcinogenic to humans
Group 2B: Possibly carcinogenic to humans
Group 3: Not classifiable as to carcinogenicity
to humans
Group 4: Probably not carcinogenic to humans
17. GROUP 1: CARCINOGENIC TO
HUMANS
Agents and groups of agents -
Such as
Arsenic and arsenic compounds
Asbestos
Benzene
Cadmium and cadmium compounds
Formaldehyde
Coal-tar pitches -Mixtures
Soots
Tobacco, smokeless
Wood dust
Exposure circumstances:
Boot and shoe manufacture and repair
Chimney sweeping
Iron and steel founding
Isopropyl alcohol manufacture (strong-acid process)
Tobacco smoking and tobacco smoke
18. GROUP 2A: PROBABLY
CARCINOGENIC TO HUMANS
Agents and groups of agents -
Such as
Androgenic (anabolic) steroids
Lead compounds, inorganic
Ultraviolet radiation
Diesel engine exhaust - Mixtures
High-temperature frying, emissions
Non-arsenical insecticides
Exposure circumstances:
Art glass, glass containers and pressed ware (manufacture of)
Carbon electrode manufacture
Cobalt metal with tungsten carbide
Hairdresser or barber (occupational exposure as a)
Petroleum refining (occupational exposures in)
Shiftwork that involves circadian disruption
Sunlamps and sunbeds (use of)
19. GROUP 2B: POSSIBLY CARCINOGENIC
TO HUMANS
Agents and groups of agents 248
Acetaldehyde
Chloroform
Cobalt and cobalt compounds
DDT
Magnetic fields (extremely low-frequency)
Naphthalene
Nickel, metallic and alloys
Coffee -Mixtures
Engine exhaust, gasoline
Fuel oils, residual (heavy)
Welding fumes
Exposure circumstances:
Carpentry and joinery
Cobalt metal without tungsten carbide
Dry cleaning (occupational exposures in)
Printing processes (occupational exposures in)
Textile manufacturing industry (work in)
20. GROUP 3: NOT CLASSIFIABLE AS TO
CARCINOGENICITY TO HUMANS
Agents and groups of agents - 515
Caffeine
Cholesterol
Coal dust
Ethylene
Mercury and inorganic mercury compounds
Talc
Mineral oils, highly-refined - Mixtures
Petroleum solvents
Printing inks
Tea
Exposure circumstances:
Flat-glass and specialty glass (manufacture of)
Hair colouring products (personal use of)
Leather goods manufacture
Lumber and sawmill industries (including logging)
Paint manufacture (occupational exposure in)
21. TAKING MEASURES
First of all, the material which is defined as
carcinogen should be forbidden in industry.
Therefore, a substitute for this material should be
researched.
If there is a need of working by carcinogens,
taking measures of decreasing exposure as
minimum is mandatory.
22. MEASURES THAT REDUCE EXPOSURE
Producing and carrying of carcinogens inside a closed system.
Measuring exposures in working atmosphere and workers
biological system.
Well working ventilation system if happens an emergency.
PPE (protective clothing, helmets, goggles, or other garments)
Rotation
Prohibiting of smoking cigarettes
23. MEASURES THAT REDUCE EXPOSURE
IMPLEMENTING REGULATION FOR THE PROTECTION OF
WORKERS FROM THE RISKS RELATED TO EXPOSURE TO
CARCINOGEN AND MUTAGEN SUBSTANCES AT WORK
Examination of the environmental or occupational site can be
performed by governmental agencies, such as the Occupational
Safety and Health Administration (OSHA) or the Environmental
Protection Agency (EPA), or by private consultants such as
certified industrial hygienists.
Air sampling performed with area or personal sampling devices to get
results that can lead to estimates of exposure based upon an average
eight-hour exposure to see deviation from permissible exposure limits
(PELs)
Toxins can be measured in air, water, soil, and from surfaces
24. Occupational Exposure Limit
OEL: the generic term for workplace exposure limits set
by specific groups
Agent: May be physical, chemical or biological
Zero exposure is not usually possible
OELs are intended to protect workers at a "safe" level of
exposure
Many chemicals have no established OEL
Use extreme precautions for agents with no safe level
Safe levels - Material Safety Data Sheets & Literature
26. THANK YOU
Chemist are the cleanest people you will ever meet
They wash their hands even before they go to the restroom !!!